Abstract
Chronic migraine (CM) is a debilitating condition that affects a significant portion of the population. Treatment for CM is a current area of research with new medications being developed. One of the latest mechanisms of action for treatment is targeting the calcitonin gene-related peptides. Two classes of drugs block that pathway, Anti-CGRP monoclonal antibodies and CGRP receptor antagonists. Another therapy that has been utilized recently for the preventative treatment of CM Onatabotulliniumtoxin A (Botox).
Included in
The Most Current and Effective Pharmaceutical Treatment Options for Chronic Migraines
Chronic migraine (CM) is a debilitating condition that affects a significant portion of the population. Treatment for CM is a current area of research with new medications being developed. One of the latest mechanisms of action for treatment is targeting the calcitonin gene-related peptides. Two classes of drugs block that pathway, Anti-CGRP monoclonal antibodies and CGRP receptor antagonists. Another therapy that has been utilized recently for the preventative treatment of CM Onatabotulliniumtoxin A (Botox).